Use of DNA repair-deficient XPA transgenic mice in short-term carcinogenicity testing

Toxicologic Pathology

Volumn 26, Issue 6, 1998, Pages 742-749

  Van Steeg, Harry ^a   Klein, Hanneke ^a   Beems, Rudolf B ^a   Van Kreijl, Coen F ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Carcinogenicity testing; DNA repair; Genotoxic; Nucleotide excision repair; Transgenic mice; Xeroderma pigmentosum; XPA

Indexed keywords

CARCINOGEN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RISK; CARCINOGEN TESTING; CARCINOGENICITY; DNA REPAIR; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; XERODERMA PIGMENTOSUM;

ANIMALIA; MAMMALIA; MUS MUSCULUS; RODENTIA;

EID: 0031775632     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1177/019262339802600605     Document Type: Article

References (24)

1. Ames BN and Gold LS (1990). Chemical carcinogenesis: Too many rodent carcinogens. Proc. Natl. Acad. Sci. USA 87: 7772-7776.
2. Asahina H, Kuraoka I, Shirakawa M, Morita EH, Miura N, Miyamoto I, Ohtsuka E, Okada Y, and Tanaka K (1994). The XPA protein is a zinc metalloprotein with an ability to recognize various kinds of DNA damage. Mutat. Res. 315: 229-237.
3. Baker SM, Bronner CE, Zhang L, Plug AW, Robatzek M, Warren G, Elliott EA, Yu J, Ashley T, Arnheim N, Flavell RA, and Liskay RM (1995). Male mice defective in the DNA mismatch repair gene PMS2 exhibit abnormal chromosome synapsis in meiosis. Cell 82: 309-319.
4. Bohr VA, Smith CA, Okumoto DS, and Hanawalt PC (1985). DNA repair in an active gene: Removal of pyrimidine dimers from the DHFR gene of CHO cells is much more efficient than in the genome overall. Cell 40: 359-369.
5. Chen M, Tomkins DJ, Auerbach W, McKerlie C, Youssoufian H, Liu L, Gan O, Carreau M, Auerbach A, Groves T, Guidos CJ, Freedman MH, Cross J, Percy DH, Dick JE, Joyner AL, and Buchwald M (1996). Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anaemia. Nat. Genet. 12: 448-451.
6. Cheo DL, Ruven HJ, Meira LB, Hammer RE, Burns DK, Tappe NJ, Van Zeeland AA, Mullenders LH, and Friedberg EC (1997). Characterization of defective nucleotide excision repair in XPC mutant mice. Mutat. Res. 374: 1-9.
7. Chu G and Mayne L (1996). Xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy: Do the genes explain the diseases? Trends Genet. 12: 187-192.
8. Cleaver JE and Kraemer KH (1989). Xeroderma pigmentosum. In: The Metabolic Basis of Inherited Disease, Vol. 2, CR Scriver, AL Beaudet, WS Sly, and D Valle (eds). McGraw-Hill, New York, pp. 2949-2971.
9. Cleaver JE and Kraemer KH (1995). Xeroderma pigmentosum and Cockayne syndrome. In: The Metabolic and Molecular Basis of Inherited Disease, CR Scriver, AL Beaudet, WS Sly, and D Valle (eds), Vol. III, 7th ed., McGraw-Hill, New York, pp. 4393-4419.
10. Cooper PK, Nouspikel T, Clarkson SG, and Leadon SA (1997). Defective transcription-coupled repair of oxidative base damage in Cockayne syndrome patients from XP group G. Science 275: 990-993.
11. Croteau DL and Bohr VA (1997). Repair of oxidative damage to nuclear and mitochondrial DNA in mammalian cells. J. Biol. Chem. 272: 25409-25412.
12. De Vries A, Van Oostrom CThM, Dortant PM, Beems RB, Van Kreijl CF, Capel PJA, and Van Steeg H (1997). Spontaneous liver tumours and benzo[a]pyrene-induced lymphomas in XPA-deficient mice. Mol. Carcinog. 19: 46-53.
13. De Vries A, Van Oostrom CThM, Hofhuis FMA, Dortant PM, Berg RJW, De Gruijl FR, Wester PW, Van Kreijl CF, Capel PJA, Van Steeg H, and Verbeek S (1995). Increased susceptibility to ultraviolet-B and carcinogens of mice lacking the DNA excision repair gene XPA. Nature 377: 169-173.
14. De Wind N, Dekker M, Berns A, Radman M, and Te Riele H (1995). Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer. Cell 82: 321-330.
15. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA, Butel JS, and Bradley A (1992). Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356: 215-221.
16. Edelmann W, Cohen PE, Kane M, Lau K, Morrow B, Bennett S, Umar A, Kunkel T, Cattoretti G, Chaganti R, Pollard JW, Kolodner RD, and Kucherlapati R (1996). Meiotic pachytene arrest in MLH1-deficient mice. Cell 85: 1125-1134.
17. Engelward BP, Weeda G, Wyatt MD, Broekhof JL, de Wit J, Donker I, Allan JM, Gold B, Hoeijmakers JHJ, and Samson LD (1997). Base excision repair deficient mice lacking the Aag alkyladenine DNA glycosylase. Proc. Natl. Acad. Sci. USA 94: 13087-13092.
18. Essers J, Hendriks RW, Swagemakers SM, Troelstra C, De Wit J, Bootsma D, Hoeijmakers JHJ, and Kanaar R (1997). Disruption of mouse RAD54 reduces ionizing radiation resistance and homologous recombination. Cell 89: 195-204.
19. Esumi H, Ohgaki H, Kohzen E, Takayama S, and Sugimura T (1989). Induction of lymphoma in CDF1 mice by the food mutagen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Jpn. J. Cancer Res. 80: 1176-1178.
20. Flammang TJ, Tungeln LSV, Kadlubar FF, and Fu PP (1997). Neonatal mouse assay for tumorigenicity: Alternative to the chronic rodent bioassay. Regul. Toxicol. Pharmacol. 26: 230-240.
21. Friedberg EC, Walker GC, and Siede W (1995). DNA Repair and Mutagenesis. American Society for Microbiology Press, Washington, D.C.
22. Gunz D, Hess MT, and Naegeli H (1996). Recognition of DNA adducts by human nucleotide excision repair: Evidence for a thermodynamic probing mechanism. J. Biol. Chem. 271: 25089-25098.
23. He Z, Henricksen LA, Wold MS, and Ingles CJ (1995). RPA involvement in the damage-recognition and incision steps of nucleotide excision repair. Nature 374: 566-569.
24. Hoeijmakers JHJ (1993). Nucleotide excision repair, I: From E. coli to yeast. Trends Genet. 9: 173-177.